글로벌 Nootropics 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

Nootropics 시장 분석

노오트로픽 시장은 소비자들 사이에서 인지 향상과 정신 건강에 대한 인식이 높아지면서 상당한 성장을 경험했습니다. 이 부문의 최근 발전에는 카페인과 L-테아닌과 같은 전통적인 노오트로픽 성분을 적응제와 허브 추출물과 같은 새로운 화합물과 결합한 혁신적인 제형의 도입이 포함됩니다. 예를 들어, 로디올라 로제아와 아슈와간다와 같은 성분이 포함된 제품의 등장은 인지 향상에 대한 전체적인 접근 방식을 추구하는 건강을 의식하는 소비자에게 어필하는 천연 및 식물성 노오트로픽에 대한 추세가 증가하고 있음을 보여줍니다. 또한 연구의 발전으로 특정 화합물이 뇌 기능에 어떻게 영향을 미칠 수 있는지에 대한 이해가 더 높아져 보다 집중적이고 효과적인 제품을 위한 길이 열렸습니다. 원격 근무와 온라인 학습의 증가는 개인이 경쟁적인 환경에서 집중력, 기억력 및 전반적인 인지 성능을 개선하고자 함에 따라 노오트로픽 보충제에 대한 수요를 더욱 촉진했습니다. 또한, 노오트로픽 보충제를 출시하기 위한 Jones Soda와 Wesana Health의 최근 파트너십과 같은 전략적 협업은 시장의 잠재력과 다양한 산업의 증가하는 관심을 강조합니다. 전반적으로, 소비자의 정신적 성과와 웰빙에 대한 관심이 커지면서 노오트로픽스 시장은 지속적으로 확대될 것으로 예상됩니다.

Nootropics 시장 규모

글로벌 노오트로픽스 시장 규모는 2023년에 141억 2천만 달러로 평가되었으며, 2031년까지 398억 8천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 13.85%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

Nootropics 시장 동향

“ 노오트로픽스에서 인공지능(AI) 도입 증가”

노오트로픽 시장은 인지 향상 및 정신적 웰빙에 대한 소비자 관심 증가로 인해 상당한 성장을 경험하고 있습니다. 주목할 만한 추세 중 하나는 식물과 허브에서 추출한 천연 노오트로픽의 인기가 높아지고 있으며, 이는 소비자에게 합성 옵션에 대한 안전한 대안을 제공합니다. 예를 들어, 적응성 허브인 로디올라 로제아는 피로를 줄이고 인지 기능을 개선하는 잠재력으로 주목을 받고 있습니다. 이러한 천연 화합물의 이점에 대한 인식이 커짐에 따라 더 많은 회사가 건강을 의식하는 소비자를 대상으로 식물성 성분을 특징으로 하는 제품을 제형하는 데 주력하고 있습니다. 이러한 추세는 개인이 집중력과 기억력을 향상시키고 전반적인 정신 건강을 지원하는 보충제를 찾고 있기 때문에 광범위한 웰빙 운동과 일치합니다. 제품 제형의 혁신과 천연 솔루션으로의 전환으로 노오트로픽 시장은 지속적인 확장을 위해 잘 자리 잡고 있으며 경쟁적인 환경에서 효과적인 인지 향상 도구에 대한 수요를 충족합니다.

보고서 범위 및 Nootropics 시장 세분화  

Nootropics Market Definition

Nootropics refer to supplements, smart drugs, cognitive enhancers, pharmaceuticals, or other substances that assist individuals in improving their cognitive functions, particularly in areas such as executive functions, motivation, creativity, and memory. They can be found in both prescription and over-the-counter forms. Prescription nootropics are medications prescribed for conditions such as Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), and narcolepsy. In contrast, non-prescription nootropics are used primarily to enhance concentration and cognitive performance rather than to address specific medical conditions.

Nootropics Market Dynamics

Drivers

• Increasing Demand for Brain Health Supplements

The demand for brain health supplements, particularly nootropic products, has surged as individuals increasingly seek ways to enhance focus, memory, and overall cognitive function.  Growth can be attributed to a significant uptick in consumer awareness regarding mental health and cognitive performance, driven by factors such as the fast-paced nature of modern life and the need for improved productivity. In addition, the rise of telecommuting and online learning has further highlighted the need for cognitive enhancement, as individuals strive to maintain sharpness and concentration in increasingly competitive environments. This growing demand is also reflected in the expansion of product offerings in the nootropic sector, with various formulations, including powders, capsules, and functional beverages, catering to the diverse needs of consumers, thereby driving the market growth.

• Rising Awareness of Cognitive Health

The rising awareness of cognitive health has significantly driven the demand for nootropics, as more consumers recognize the vital role that mental performance plays in their daily lives. According to a survey conducted by the National Institute on Aging, approximately 60% of older adults are concerned about maintaining their cognitive function as they age, which has led to an increased interest in supplements that claim to enhance memory, focus, and overall brain health. Such trend is further fueled by the increasing availability of information about cognitive enhancers through digital media and health platforms, leading consumers to seek out nootropics as proactive solutions for mental clarity and performance. As awareness continues to grow, it is expected that the market for nootropics will expand, driven by both preventive health measures and the desire for enhanced cognitive abilities.

Opportunities

• Rising Expansion of E-Commerce

The expansion of e-commerce presents a significant opportunity for nootropic brands to tap into a broader consumer base, particularly as online shopping continues to grow in popularity. E-commerce platforms enable brands to utilize targeted marketing strategies, reaching specific demographics interested in cognitive enhancement. For instance, companies such as Nootrobox, which specializes in nootropic supplements, have successfully leveraged online platforms to offer their products directly to consumers, utilizing social media advertising and influencer partnerships to drive awareness and sales. In addition, e-commerce allows for customer reviews and ratings, which can significantly influence purchasing decisions, helping brands build trust and credibility. With the convenience of online shopping, consumers can easily compare different nootropic products, read detailed descriptions, and access educational content, ultimately leading to increased sales and customer loyalty. As more individuals turn to digital solutions for their health and wellness needs, market players can capitalize on the widened opportunites created through e commerce.

• Increasing Investing in Research and Development (R&D)

Investing in research and development (R&D) is crucial for nootropic companies aiming to establish themselves as leaders in the competitive cognitive enhancement market. Ongoing research into the efficacy of various nootropic ingredients validates their benefits and opens the door to the development of new, innovative products that can address specific cognitive needs. For instance, Neurohacker Collective, known for its nootropic product Qualia Mind, actively invests in R&D to explore the synergistic effects of ingredients such as citicoline, bacopa monnieri, and L-theanine. This commitment to scientific inquiry has allowed them to enhance their formulations continually and substantiate their claims with clinical data, thereby building consumer trust. As the demand for effective cognitive enhancers rises, companies that prioritize R&D will be better positioned to introduce cutting-edge products that meet consumer expectations, differentiate themselves from competitors, and ultimately creating opportunities in the market.

Restraints/Challenges

• Uncertain Regulation Across Regions

Regulatory uncertainty poses a significant challenge in the global nootropics market, as the absence of standardized regulations can result in inconsistent quality and safety standards for these supplements. Different countries enforce varying regulations concerning the formulation, labeling, and marketing of nootropic products, complicating the ability of companies to navigate compliance and maintain uniformity across international markets. For instance, while the U.S. Food and Drug Administration (FDA) regulates dietary supplements, it does not require pre-market approval, allowing a wide range of products to enter the market with minimal oversight. In contrast, countries such as Australia have stricter regulations that classify certain nootropics as prescription medications, requiring rigorous testing and approval processes. This disparity can create barriers for companies attempting to market their products globally, as they must adapt to different regulatory landscapes, potentially increasing costs and limiting access to certain markets. Consequently, the lack of a cohesive regulatory framework can hinder innovation and hampers the growth in the market.

• Side Effects and Safety Concerns

Side effects and safety concerns represent a significant challenge for the nootropics market, as certain ingredients may cause adverse reactions or interact negatively with other medications. For instance, substances such as phenylpiracetam and modafinil are known for their cognitive-enhancing effects, but they can also lead to side effects such as increased heart rate, anxiety, or insomnia, particularly in sensitive individuals. In addition, these nootropics may interact with common medications, such as antidepressants or blood pressure drugs, complicating their use for consumers with existing health conditions. This potential for negative health impacts can deter consumers from trying nootropic products, which poses a market challenge for companies aiming to build a loyal customer base. Consequently, hindering the overall market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Nootropics Market Scope

The market is segmented on the basis of type, indication, dosage form, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Over-the-counter (OTC)
• Prescription
• Natural
• Homemade
• Others

Indication

• Productivity and Study
• Socializing
• Exercise and Health
• Wellbeing
• Others

Dosage Form

• Tablets
• Capsules
• Injections
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Nootropics Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, indication, dosage form, route of administration, end user, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is leading the global nootropics market, driven by the increasing emphasis from major players on innovative technologies and advancements in cognitive enhancement solutions. In addition, the region's rising investment in healthcare and research and development is expected to significantly boost the growth rate of the nootropics market. As a result, North America is well-positioned to maintain its dominance in this rapidly evolving sector, attracting further interest and resources from both established companies and emerging startups.

Asia-Pacific region is anticipated to experience significant growth in the nootropics market during the forecast period of 2024-2031, largely driven by an increasing awareness of cognitive health supplements among consumers. This heightened awareness is encouraging more individuals to seek out products that enhance mental performance and overall cognitive function. Furthermore, advancements in healthcare infrastructure across various countries in the region are expected to facilitate greater accessibility to these supplements, thereby accelerating market growth and fostering a more informed consumer base.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Nootropics Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Nootropics Market Leaders Operating in the Market Are:

• Pfizer Inc. (U.S.)
• GSK plc (영국)
• 노바티스 AG(스위스)
• Viatris Inc. (미국)
• Teva Pharmaceutical Industries Ltd. (이스라엘)
• 사노피(프랑스)
• 아스트라제네카(영국)
• 존슨앤존슨 서비스 주식회사(미국)
• Reckitt Benckiser Group PLC(영국)
• Onnit Labs, Inc. (미국)
• 멘탈 모조, LLC (미국)
• NooCube(영국)
• 비타블렌드(네덜란드)
• 트루브레인(미국)
• 주 영양학(유타)

Nootropics 시장의 최신 동향

• 2023년 5월, Nature's Way는 뇌 건강을 지원하고 빠르게 성장하는 인지 제품 시장을 개척하기 위해 만들어진 최신 노오트로픽 젤리를 출시했습니다. 이 제품은 성인이 단기 기억력, 집중력, 집중력을 향상시키는 데 도움이 되도록 고안되었습니다. 현재 Kroger, Meijer, Giant Company와 같은 소매업체와 다양한 천연 식품 매장에서 판매됩니다.
• 2022년 9월, Reckitt이 소유한 인지 건강 보충제 브랜드인 Neuriva는 셰프이자 음식 애호가인 Alton Brown과 협력하여 뇌 건강에 대한 전체론적 접근 방식을 옹호했습니다. 이 협업은 소비자들이 뇌 건강이 전반적인 웰빙의 필수적인 부분임을 인식하도록 장려하는 것을 목표로 했습니다. 이 파트너십은 Neuriva Plus와 Neuriva Sleep, Neuriva Brain + Energy와 같은 새로 출시된 품목을 포함한 Neuriva의 제품군을 강조했습니다.
• 2022년 8월, 영국에 본사를 둔 노오트로픽 제품 공급업체인 Nu는 노오트로픽 스낵 바의 새로운 라인을 공개했습니다. 이 바는 노르웨이산 검은 귀리로 만들어졌으며 콜린, 포스파티딜세린, 오메가-3 지방산을 포함한 중요한 뇌 영양소가 풍부합니다. 메이플과 피칸, 소금 카라멜, 건포도와 아몬드, 사과와 계피 등 다양한 맛으로 제공됩니다.
• 2022년, Jones Soda는 Mike Tyson과 Wesana Health와 협력하여 개발한 획기적인 노오트로픽 보충제를 출시했습니다. 이 혁신적인 제품은 인지 기능과 정신적 명확성을 향상시키는 것을 목표로 하며, 보충제 시장에서 독특한 제품으로 자리매김하고 있습니다. Tyson의 스타 파워와 Wesana Health의 정신 건강 전문 지식을 결합하여 Jones Soda는 뇌 강화 보충제에 대한 증가하는 수요를 활용하고 있습니다.
• 2021년 10월, 호주 스타트업 Savvy Beverage는 인지 기능 향상을 목표로 하는 노트로픽 성분이 주입된 인스턴트 커피와 소다 음료를 출시한다고 발표했습니다. 이 제품 라인은 네스프레소 머신과 호환되는 기존 기능성 커피 포드 제품군을 확장하여 소비자에게 이동 중에도 정신적 성과를 향상시킬 수 있는 편리한 옵션을 제공합니다.

SKU-53522